Watermark
  Back to Search Results

BGB-3111-212

Completed

A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-212

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03332017

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2023-509975-17-00

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20220712

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan